Dapasmart Tablet (Dapagliflozin) | Used for Type 2 Diabetes and Blood Sugar Control
Dapasmart Tablet (Dapagliflozin) is an antidiabetic medicine used to control blood sugar levels in type 2 diabetes. It helps the body remove excess glucose through urine, improving glycemic control and supporting better diabetes management when combined with diet and exercise.
Product Overview
Dapasmart Tablet is an advanced prescription treatment clinically indicated for the effective management of type 2 diabetes mellitus. Formulated to help adults regulate fluctuating blood sugar levels, this oral antidiabetic medication serves as an essential adjunct to dietary modifications and regular physical exercise. Beyond glucose regulation, the active therapy provides substantial cardiorenal protection, significantly reducing the risks of cardiovascular complications, heart failure hospitalization, and progressive kidney damage in vulnerable diabetic patients.
Product Composition
Active Pharmaceutical Ingredient: Each therapeutic tablet delivers either Dapaglflozin 5mg or Dapagliflozin 10mg depending on the specific prescribed strength.
Therapeutic Drug Class: Functions as a highly potent and selective SGLT2 inhibitor (sodium-glucose cotransporter 2 inhibitor).
Inactive Core Composition: Formulated with microcrystalline cellulose, anhydrous lactose, crospovidone, silicon dioxide, magnesium stearate, and a moisture-protective film coating.
Product Specification
| Product Attribute | Specification |
| Brand Identity | Dapasmart Tablet |
| Generic Substance | Dapagliflozin |
| Available Strengths | 5mg and 10mg formulations |
| Therapeutic Class | Antidiabetic / SGLT2 Inhibitor |
| Primary Indication | Glycemic control in Type 2 Diabetes Mellitus |
| Secondary Indications | Heart failure protection and Chronic Kidney Disease support |
Mechanism of Action
- Renal Transporter Blockade: The active compound works within the kidneys by selectively targeting and blocking the SGLT2 protein located in the proximal renal tubules.
- Glucose Reabsorption Prevention: By inhibiting this specific transport system, it effectively stops the kidneys from absorbing approximately ninety percent of filtered glucose back into the systemic circulation.
- Glucosuria Induction: It shifts excess blood sugar directly into the renal filtration system, facilitating the excretion of redundant glucose through the patient's urine.
- Insulin Independent Pathway: Operates entirely via an insulin independent mechanism, providing steady blood sugar control without straining pancreatic beta cells or causing intrinsic low blood sugar risks.
Key Benefits
- Superior Glycemic Control: Consistently lowers HbA1c levels and stabilizes baseline fasting and post-meal blood sugar measurements.
- Cardiovascular System Protection: Markedly decreases the overall incidence of major adverse cardiac events and mitigates the risk of sudden heart failure hospitalizations.
- Renal Disease Preservation: Helps slow down the long-term decline of kidney function (estimated glomerular filtration rate) while lowering excess protein excretion in the urine.
- Metabolic Management Advantages: Promotes a modest reduction in both systolic blood pressure and overall body weight due to steady, daily caloric loss from glucose excretion.
Precautions
Before using Dapasmart Tablet (Dapagliflozin), certain precautions should be followed to ensure safe and effective use in managing type 2 diabetes.
| Precaution | Details |
|---|---|
| Kidney Function | Use carefully in kidney disease. |
| Dehydration Risk | May cause fluid loss. Stay hydrated. |
| Low Blood Sugar | Risk increases with other diabetes medicines. |
| Infections | May increase risk of urinary infections. |
| Surgery | Inform before any surgical procedure. |
| Pregnancy & Breastfeeding | Use only after medical advice. |
| Allergy | Avoid if allergic to Dapagliflozin. |
Important Safety Advice
- Monitor blood sugar levels regularly
- Maintain proper hydration during use
- Follow diet and exercise plan for best results
- Avoid skipping or doubling doses
- Inform about all medicines being taken
When to Take Extra Care
- Kidney-related health issues
- Recurrent urinary infections
- Low blood pressure or dehydration symptoms
- Concurrent use of insulin or other diabetes medicines
Usage
Proper administration of this oral antidiabetic medication is vital to maximize its blood sugar-lowering effects and ensure optimal systemic safety. Patients must adhere strictly to their medical guidance to achieve consistent metabolic control.
Standard Therapeutic Dosage: The initial recommended dosage for glycemic control is Dapagliflozin 10mg taken once daily, though a lower dose of 5mg may be utilized based on specific patient parameters or severe hepatic impairment.
Administration Guidelines: The tablet must be swallowed whole with a glass of water and should be taken at approximately the same time every single day.
Dietary Flexibility: This medication can be administered comfortably with or without food, as its systemic absorption is not altered by meal intake.
Missed Dose Protocol: If a dose is missed, it should be taken as soon as remembered on that day. If it is almost time for the next scheduled dose, skip the missed one entirely. Never take two tablets at once to compensate.
Administration Schedules
| Administrative Parameter | Required Protocol | Clinical Justification |
| Daily Administration | One tablet exactly every twenty four hours | Maintains a constant, steady concentration of the SGLT2 inhibitor in the body |
| Hydration Requirements | Increased daily intake of water and clear fluids | Prevents the development of dehydration, volume depletion, and sudden low blood pressure |
| Renal Function Threshold | Periodic blood tests to evaluate the estimated glomerular filtration rate | The medication relies heavily on adequate kidney function to effectively filter out excess blood sugar |
| Surgical Discontinuation | Temporary pause required prior to scheduled major surgeries | Significantly minimizes the underlying risk of developing diabetic ketoacidosis |
Uses
Dapasmart Tablet provides comprehensive systemic benefits that extend far beyond basic glycemic regulation. The primary Dapagliflozin uses encompass glycemic control, cardiac protection, and long-term renal preservation.
Glycemic Management: Extensively indicated as an adjunct to diet and exercise to lower HbA1c and maintain stable blood sugar levels in adults with type 2 diabetes mellitus.
Heart Failure Mitigation: Clinically used to significantly reduce the risk of cardiovascular death and urgent hospitalization in patients suffering from chronic heart failure with reduced ejection fraction.
Chronic Kidney Disease Support: Prescribed to slow down the progressive loss of renal function and reduce the risk of end-stage kidney disease in individuals vulnerable to chronic renal decline.
Cardiovascular Risk Reduction: Utilized to shield diabetic patients with established cardiovascular disease from experiencing serious adverse cardiac events and related vascular complications.
Side Effects
Dapasmart Tablet (Dapagliflozin) may cause side effects in some patients. Most effects are mild and temporary, but some may require medical attention.
| Side Effect | Details |
|---|---|
| Urinary Infection | Increased risk of UTI. |
| Increased Urination | More frequent passing of urine. |
| Thirst | Dry mouth or increased thirst. |
| Dizziness | Feeling lightheaded or weak. |
| Low Blood Sugar | Especially with other medicines. |
| Fatigue | Feeling tired or low energy. |
| Genital Infections | Fungal infections may occur. |
Common Side Effects
- Frequent urination
- Thirst and dry mouth
- Mild dizziness
- Fatigue or weakness
Less Common Effects
- Urinary tract infections
- Genital fungal infections
- Mild dehydration
- Low blood pressure
Serious Side Effects (Seek Help Immediately)
- Severe dehydration symptoms
- Persistent or painful infections
- Severe dizziness or fainting
- Signs of allergic reaction like rash, swelling, or breathing difficulty
FAQs
Q: What is the product used for?
A: Dapasmart Tablet is a prescription medication primarily used to improve blood sugar control in adults with type 2 diabetes mellitus. It is also prescribed to reduce the risk of hospitalization for heart failure and to slow the progression of chronic kidney disease.
Q: What is the active component in this medication?
A: The primary active ingredient is Dapagliflozin, which belongs to a class of medications called sodium-glucose cotransporter 2 inhibitors, commonly referred to as an SGLT2 inhibitor.
Q: How does this medicine help lower blood sugar?
A: The tablet works directly on the kidneys to block the reabsorption of glucose back into the body. This forces the excess blood sugar to be filtered out and removed from the system naturally through urination.
Q: When is the best time to take this oral antidiabetic medication?
A: It should be taken once daily at approximately the same time every morning. It can be taken safely either with a meal or on an empty stomach with a full glass of water.
Q: What should be done if a daily dose is missed?
A: Take the missed tablet as soon as you remember it on that day. However, if your next scheduled dose is less than twelve hours away, skip the missed tablet completely and return to your normal routine. Do not double the dose.
Q: Can this tablet cause blood sugar levels to drop too low?
A: When used on its own, this medication has a very low risk of causing hypoglycemia because it operates via an insulin-independent pathway. The risk of low blood sugar increases only if it is combined with other diabetic treatments like insulin or sulfonylureas.
Q: What are the most common side effects associated with this medication?
A: The most frequent side effects include a higher frequency of urination, mild dehydration, thirst, and an increased susceptibility to genital yeast infections or urinary tract infections due to the elevated sugar levels in the urine.
Q: Why is it important to stay well-hydrated during treatment?
A: Because the medication removes excess sugar and fluid through the urine, it can lead to mild volume depletion. Drinking plenty of water throughout the day prevents dehydration and helps maintain stable blood pressure.
Interactions
Dapasmart Tablet (Dapagliflozin) may interact with certain medicines and health conditions, which can affect blood sugar control or increase side effects.
| Interaction Type | Details |
|---|---|
| Insulin | May increase risk of low blood sugar. |
| Other Diabetes Medicines | Can enhance glucose lowering effect. |
| Diuretics | May increase dehydration risk. |
| Blood Pressure Medicines | May lower blood pressure further. |
| NSAIDs | May affect kidney function. |
| Alcohol | Can increase risk of dehydration. |
| Kidney Disease | May reduce medicine effectiveness. |
Medicines That May Interact
- Insulin therapy
- Sulfonylureas and other antidiabetic drugs
- Diuretics used for fluid retention
- Medicines for high blood pressure
- Pain relievers like NSAIDs
Important Considerations
- Always share your full medicine list
- Monitor blood sugar regularly
- Stay hydrated during treatment
- Watch for dizziness or weakness
- Avoid self-adjusting doses without advice
| Manufacturer | : | Healing Pharma |
| Trade Name | : | Farxiga |
| Generic Search | : | Dapagliflozin |
| Strength | : | 5 mg, 10 mg |
Latest Products
